Bank Of America Corp Fate Therapeutics Inc Transaction History

Bank Of America Corp

$1.21 Trillion
Q1 2025

A detailed history of Bank Of America Corp transactions in Fate Therapeutics Inc stock. As of the latest transaction made, Bank Of America Corp holds 388,443 shares of FATE stock, worth $392,327. This represents 0.0% of its overall portfolio holdings.

Number of Shares

388,443

Previous 304,129 27.72%

Holding current value

$392,327

Previous $501,000 38.92%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$0.79 - $1.87 $66,608 - $157,667	84,314 Added 27.72%	388,443 $306,000
Q4 2024 Feb 14, 2025	SELL	$1.61 - $3.35 $885,606 - $1.84 Million	-550,066 Reduced 64.4%	304,129 $501,000
Q3 2024 Nov 14, 2024	SELL	$3.12 - $5.57 $3.53 Million - $6.3 Million	-1,131,537 Reduced 56.98%	854,195 $2.99 Million
Q2 2024 Aug 14, 2024	BUY	$3.26 - $7.08 $215,016 - $466,968	65,956 Added 3.44%	1,985,732 $6.51 Million
Q1 2024 May 15, 2024	BUY	$3.54 - $8.35 $4.65 Million - $11 Million	1,312,772 Added 216.27%	1,919,776 $14.1 Million
Q4 2023 Feb 14, 2024	SELL	$1.65 - $3.94 $1.01 Million - $2.42 Million	-614,904 Reduced 50.32%	607,004 $2.27 Million
Q2 2023 Aug 14, 2023	SELL	$4.76 - $6.59 $4.44 Million - $6.15 Million	-932,621 Reduced 43.29%	1,221,908 $5.82 Million
Q1 2023 May 12, 2023	BUY	$4.24 - $11.12 $7.11 Million - $18.6 Million	1,676,652 Added 350.85%	2,154,529 $12.3 Million
Q4 2022 Feb 10, 2023	BUY	$9.86 - $23.83 $1.41 Million - $3.41 Million	142,932 Added 42.67%	477,877 $4.82 Million
Q3 2022 Nov 14, 2022	BUY	$21.04 - $36.06 $349,390 - $598,812	16,606 Added 5.22%	334,945 $7.51 Million
Q2 2022 Aug 12, 2022	SELL	$17.78 - $42.39 $102,626 - $244,675	-5,772 Reduced 1.78%	318,339 $7.89 Million
Q1 2022 May 16, 2022	SELL	$29.67 - $60.28 $1.75 Million - $3.56 Million	-59,086 Reduced 15.42%	324,111 $12.6 Million
Q4 2021 Feb 08, 2022	BUY	$47.84 - $64.34 $6.79 Million - $9.14 Million	142,026 Added 58.89%	383,197 $22.4 Million
Q3 2021 Nov 15, 2021	SELL	$59.27 - $95.73 $1.42 Million - $2.29 Million	-23,921 Reduced 9.02%	241,171 $14.3 Million
Q2 2021 Sep 13, 2021	BUY	$67.25 - $92.52 $17.8 Million - $24.5 Million	265,092 New	265,092 $23 Million

Others Institutions Holding FATE

# of Institutions

144

Shares Held

96M

Call Options Held

56.7K

Put Options Held

5.4K

View Full List

About FATE THERAPEUTICS INC

Ticker FATE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,000,304
Market Cap $98M
Description
Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...

More about FATE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Account

Bank Of America Corp Fate Therapeutics Inc Transaction History